Results 221 to 230 of about 14,528 (265)

Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years.

EuroIntervention, 2019
AIMS The aim of this study was to determine the long-term outcomes of high-risk patients who underwent transcatheter aortic valve implantation (TAVI) with the third-generation CoreValve device, according to the 2017 EAPCI/ESC/EACTS definition of valve ...
R. Panico, C. Giannini, M. De Carlo, M. Angelillis, P. Spontoni, A. Pieroni, G. Costa, P. Bertini, F. Guarracino, A. Petronio   +9 more
semanticscholar   +1 more source

The INTACT Bioprosthesis - Early Results

Journal of Cardiac Surgery, 1988
The INTACT (previously Xenotech) valve incorporates three major departures from previously available bioprostheses. The following innovations are aimed at reducing calcification and improving durability: (1) the stent has a high profile configuration and the sinuses are deeply excavated.
openaire   +2 more sources

The Hancock II bioprosthesis at 12 years

The Annals of Thoracic Surgery, 1998
The Hancock II bioprosthesis has been used for heart valve replacement since 1982 in our institution. We previously reported its clinical performance at 8 years and at 10 years. This is a progress report on its performance at 12 years.From 1982 to 1994 the Hancock II bioprosthesis was used for aortic valve replacement (AVR) in 723 patients and for ...
T E, David, S, Armstrong, Z, Sun
openaire   +2 more sources

The Freestyle Aortic Bioprosthesis: A Systematic Review

Heart, Lung and Circulation, 2014
The Medtronic Freestyle bioprosthesis (FSB) provides an alternative to other prostheses for both aortic valve and aortic root surgery. This paper is a systematic review of the post-operative outcomes in patients with aortic valve and/or aortic root disease following FSB implantation.Electronic databases were searched for primary analysis, prospective ...
Andrew G, Sherrah, J James B, Edelman, Shane R, Thomas, Peter W, Brady, Michael K, Wilson, Richmond W, Jeremy, Paul G, Bannon, Michael P, Vallely   +7 more
openaire   +2 more sources

Early Degeneration Caused by Cusp Tear of First-Generation Trifecta Bioprosthesis.

Annals of Thoracic Surgery, 2018
The Trifecta aortic valve has excellent hemodynamic performance as result of an expansive valve design with a bovine pericardial sheet externally mounted on a titanium stent.
S. Eichinger, A. Badreldin, W. Eichinger
semanticscholar   +1 more source

Repositionable self-expanding aortic bioprosthesis

Expert Review of Medical Devices, 2017
Transcatheter aortic valve implantation/replacement (TAVI or TAVR) has been established as a first line therapy in patients with symptomatic severe aortic stenosis (AS) at high or prohibitive surgical risk and as an alternative in elderly patients with intermediate surgical risk.
Bruna Gomes, Hugo A. Katus, Raffi Bekeredjian   +2 more
openaire   +2 more sources

The New Labcor-Santiago Pericardial Bioprosthesis

Journal of Cardiac Surgery, 1991
The Labcor-Santiago pericardial valve has been designed to minimize mechanical stress and to avoid abrasion wear, at the same time preserving the concept of mounting the pericardium outside the posts for full orifice opening. The new design has preserved the traditional superior hemodynamic performance of pericardial valves, avoiding abrasion by ...
J B, Garcia-Bengochea, I, Casagrande, J R, Gonzalez-Juanatey, L, Puig, J, Rubio, D, Duran, J, Sierra   +6 more
openaire   +2 more sources

Aspergillus cyst of aortic valve bioprosthesis

Journal of Echocardiography, 2011
Aspergillus endocarditis (AE) is an ominous complication of cardiac surgery with a dismal prognosis. We present a 35-year-old female who developed AE 4 months after her aortic and mitral valve replacement. Transesophageal echocardiography revealed an aortic root abscess and a cystic mass attached to the aortic bioprosthesis.
Ashraf M, Anwar, Youssef F M, Nosir, Mirvat, Al-Asnaj, Walid, Abukhudair, Abdullah, Ashmeg, Hassan, Chamsi-Pasha   +5 more
openaire   +2 more sources

Pregnancy in patients with a porcine valve bioprosthesis

The American Journal of Cardiology, 1982
Seven patients who became pregnant after valve replacement with a Hancock bioprosthesis were followed up during 8 pregnancies. Six had undergone isolated mitral valve replacement, and 1 had mitral and aortic valve replacement. Their age at the time of operation ranged from 14 to 31 years (average 24); delivery occurred 21 to 88 months (average 51.3 ...
BORTOLOTTI U, MILANO A, MAZZUCCO A, VALFRE C, RUSSO R, VALENTE, MARIALUISA, SCHIVAZAPPA, L, THIENE, GAETANO, GALLUCCI V. AM J. C.A.R.D.I.O.L. NOV   +8 more
openaire   +4 more sources

The Intact bioprosthesis: The first 4 years

The Annals of Thoracic Surgery, 1989
The Intact porcine bioprosthesis became available for clinical use in 1984. The device incorporates three innovations aimed at reducing calcification and improving durability. Between October 1984 and March 1988, 221 valves were implanted in 200 patients.
openaire   +2 more sources